Charles River Laboratories International CRL
$ 230.09
-2.21%
Facebook
Twitter
Telegram
Report an ErrorCharles River Laboratories International Balance Sheet 2011-2024 | CRL
Annual Balance Sheet Charles River Laboratories International
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
2.43 B | 2.52 B | 2.45 B | -154 M | 1.65 B | 1.47 B | 981 M | 1.12 B | 745 M | 618 M | 508 M | 557 M | 649 M |
Long Term Debt |
2.65 B | 2.71 B | 2.66 B | 50.2 M | 1.85 B | 1.64 B | 1.11 B | 1.21 B | 846 M | 746 M | 642 M | 527 M | 703 M |
Long Term Debt Current |
54.9 M | 46.5 M | 33.3 M | 24.7 M | 20.4 M | 28.2 M | 28.5 M | 24.6 M | 15.2 M | 31.7 M | 21.2 M | -139 M | 14.7 M |
Total Non Current Liabilities |
- | - | - | - | 2.35 B | 1.98 B | 1.42 B | 1.44 B | 1.02 B | 917 M | 757 M | 643 M | 814 M |
Total Current Liabilities |
1.06 B | 1.09 B | 1.03 B | 840 M | 710 M | 558 M | 464 M | 430 M | 312 M | 296 M | 247 M | 342 M | 217 M |
Total Liabilities |
4.54 B | 4.58 B | 4.43 B | 3.35 B | 3.06 B | 2.54 B | 1.88 B | 1.87 B | 1.34 B | 1.21 B | 1 B | 986 M | 1.03 B |
Deferred Revenue |
242 M | 264 M | 220 M | 208 M | 172 M | 145 M | 118 M | 128 M | 81.3 M | 78.1 M | 54.2 M | 56.4 M | 56.5 M |
Retained Earnings |
1.89 B | 1.43 B | 981 M | 625 M | 280 M | 42.1 M | 289 M | 165 M | 10.5 M | -139 M | -266 M | -368 M | -466 M |
Total Assets |
8.2 B | 7.6 B | 7.02 B | 5.49 B | 4.69 B | 3.86 B | 2.93 B | 2.71 B | 2.07 B | 1.89 B | 1.64 B | 1.59 B | 1.56 B |
Cash and Cash Equivalents |
277 M | 234 M | 246 M | 228 M | 238 M | 195 M | 164 M | 118 M | 118 M | 160 M | 156 M | 110 M | 68.9 M |
Book Value |
3.66 B | 3.02 B | 2.59 B | 2.14 B | 1.63 B | 1.32 B | 1.05 B | 839 M | 733 M | 672 M | 641 M | 601 M | 527 M |
Total Shareholders Equity |
3.6 B | 2.98 B | 2.54 B | 2.12 B | 1.63 B | 1.32 B | 1.05 B | 837 M | 733 M | 672 M | 641 M | 601 M | 526 M |
All numbers in USD currency
Quarterly Balance Sheet Charles River Laboratories International
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
2.51 B | 2.68 B | 2.74 B | 2.71 B | 2.94 B | - | 2.68 B | 2.66 B | 2.89 B | 2.73 B | 2.2 B | 1.93 B | 1.93 B | 1.93 B | 1.93 B | 1.85 B | 1.85 B | 1.85 B | 1.85 B | 1.63 B | 1.64 B | 1.79 B | 1.11 B | 1.09 B | 1.09 B | 1.09 B | 1.09 B | 1.19 B | 1.19 B | 1.19 B | 1.19 B | 821 M | 821 M | 821 M | 821 M | 722 M | 722 M | 722 M | 722 M | 642 M | 642 M | 642 M | 642 M | 527 M | 527 M | 527 M | 527 M | 703 M | 703 M | 703 M | 703 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
4.26 B | 4.47 B | 4.54 B | 4.58 B | 4.71 B | - | 4.4 B | 4.43 B | 4.59 B | 4.37 B | 3.59 B | 3.35 B | 3.35 B | 3.35 B | 3.35 B | 3.03 B | 3.03 B | 3.03 B | 3.03 B | 2.52 B | 2.52 B | 2.52 B | 2.52 B | 1.87 B | 1.87 B | 1.87 B | 1.87 B | 1.86 B | 1.86 B | 1.86 B | 1.86 B | 1.3 B | 1.3 B | 1.3 B | 1.3 B | 1.17 B | 1.18 B | 1.18 B | 1.18 B | 968 M | 968 M | 968 M | 968 M | 983 M | 983 M | 983 M | 983 M | 1.03 B | 1.03 B | 1.03 B | 1.03 B |
Deferred Revenue |
250 M | 257 M | 262 M | 264 M | 251 M | - | 228 M | 220 M | 222 M | 231 M | 213 M | 208 M | 208 M | 208 M | 208 M | 172 M | 172 M | 172 M | 172 M | 145 M | 145 M | 145 M | 98.5 M | 118 M | 109 M | 119 M | 128 M | 128 M | 128 M | 128 M | 128 M | 81.3 M | 81.3 M | 81.3 M | 81.3 M | 78.1 M | 78.1 M | 78.1 M | 78.1 M | 54.2 M | 54.2 M | 54.2 M | 54.2 M | 56.4 M | 56.4 M | 56.4 M | 56.4 M | 56.5 M | 56.5 M | 56.5 M | 56.5 M |
Retained Earnings |
1.72 B | 1.63 B | 1.54 B | 1.43 B | 1.28 B | - | 1.07 B | 981 M | 879 M | 775 M | 687 M | 625 M | 625 M | 625 M | 625 M | 280 M | 280 M | 280 M | 280 M | 42.1 M | 42.1 M | 42.1 M | 42.1 M | 289 M | 289 M | 289 M | 289 M | 165 M | 165 M | 165 M | 165 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | -139 M | -139 M | -139 M | -139 M | -265 M | -265 M | -265 M | -265 M | -368 M | -368 M | -368 M | -368 M | -466 M | -466 M | -466 M | -466 M |
Total Assets |
7.61 B | 7.77 B | 7.7 B | 7.6 B | 7.38 B | - | 7.08 B | 7.02 B | 7.06 B | 6.72 B | 5.81 B | 5.49 B | 5.49 B | 5.49 B | 5.49 B | 4.69 B | 4.69 B | 4.69 B | 4.69 B | 3.86 B | 3.86 B | 3.86 B | 3.86 B | 2.93 B | 2.93 B | 2.93 B | 2.93 B | 2.71 B | 2.71 B | 2.71 B | 2.71 B | 2.07 B | 2.07 B | 2.07 B | 2.07 B | 1.87 B | 1.88 B | 1.88 B | 1.89 B | 1.63 B | 1.63 B | 1.63 B | 1.63 B | 1.59 B | 1.59 B | 1.59 B | 1.59 B | 1.56 B | 1.56 B | 1.56 B | 1.56 B |
Cash and Cash Equivalents |
157 M | 200 M | 202 M | 234 M | 196 M | 207 M | 242 M | 241 M | 213 M | 223 M | 465 M | 228 M | 228 M | 228 M | 228 M | 238 M | 238 M | 238 M | 238 M | 195 M | 195 M | 195 M | 195 M | 164 M | 164 M | 164 M | 164 M | 118 M | 118 M | 118 M | 118 M | 118 M | 118 M | 118 M | 118 M | 160 M | 160 M | 160 M | 160 M | 156 M | 156 M | 156 M | 156 M | 110 M | 110 M | 110 M | 110 M | 68.9 M | 68.9 M | 68.9 M | 68.9 M |
Book Value |
3.35 B | 3.3 B | 3.16 B | 3.02 B | 2.67 B | - | 2.67 B | 2.59 B | 2.46 B | 2.35 B | 2.22 B | 2.14 B | 2.14 B | 2.14 B | 2.14 B | 1.67 B | 1.67 B | 1.67 B | 1.67 B | 1.34 B | 1.34 B | 1.34 B | 1.34 B | 1.06 B | 1.06 B | 1.06 B | 1.06 B | 854 M | 854 M | 854 M | 854 M | 766 M | 766 M | 766 M | 766 M | 704 M | 704 M | 704 M | 704 M | 665 M | 665 M | 665 M | 665 M | 603 M | 603 M | 603 M | 603 M | 527 M | 527 M | 527 M | 527 M |
Total Shareholders Equity |
3.31 B | 3.25 B | 3.11 B | 2.98 B | 2.63 B | 2.65 B | 2.61 B | 2.53 B | 2.43 B | 2.32 B | 2.18 B | 2.11 B | 2.11 B | 2.11 B | 2.11 B | 1.63 B | 1.63 B | 1.63 B | 1.63 B | 1.32 B | 1.32 B | 1.32 B | 1.32 B | 1.05 B | 1.05 B | 1.05 B | 1.05 B | 837 M | 837 M | 837 M | 837 M | 733 M | 733 M | 733 M | 733 M | 672 M | 672 M | 672 M | 672 M | 641 M | 641 M | 641 M | 641 M | 601 M | 601 M | 601 M | 601 M | 526 M | 526 M | 526 M | 526 M |
All numbers in USD currency